子宫内膜癌分子分型应用于子宫内膜活检标本:迈向早期个体化管理
本研究收集50例子宫内膜癌活检及对应子宫切除标本,另纳入10例活检为不典型增生/EIN而切除后证实为癌的病例,比较活检与切除标本在肿瘤分级、组织学亚型、错配修复蛋白、P53及POLE突变方面的一致性。结果显示MMR缺失、MSI高、P53野生型及异常型一致性高,分级与组织学亚型仅中等一致;POLE突变仅2例且仅见于切除标本。
要点
- 子宫内膜癌活检与子宫切除标本在MMR缺失、MSI高、P53野生型及异常型上一致性高。
- 肿瘤分级与组织学亚型在活检与切除标本间仅呈中等一致性。
- POLE突变检测一致性不足,本研究中仅2例且均仅见于切除标本。
核心结论
- 在本队列中,活检与子宫切除标本在MMR缺失、MSI高、P53野生型及异常型方面一致性高,优于分级和组织学亚型,可提供更早、更可靠的预后信息以指导管理。
- 由于本研究中POLE突变频率低,POLE突变未能达到类似的一致性。
研究设计与样本
- 收集50例子宫内膜癌活检及对应子宫切除标本,另纳入10例活检为不典型增生/EIN而切除后证实为子宫内膜癌的病例。
- 采用免疫组化检测错配修复蛋白(MLH1、PMS2、MSH2、MSH6)和P53,PCR进行微卫星不稳定性分析,Sanger测序检测POLE基因外显子9和13突变。
- 使用Cohen kappa评估活检与切除标本在肿瘤分级、组织学亚型、免疫组化及分子分型上的一致性。
主要发现
- MMR缺失、MSI高、P53野生型及异常型在活检与子宫切除标本间达到高一致性。
- 肿瘤分级和组织学亚型在活检与子宫切除标本间仅呈中等一致性。
- POLE基因突变在2例患者中检出,两例均仅在切除标本中检测到突变。
- 活检为不典型增生/EIN而切除后证实为癌的病例,其分子分型与子宫内膜癌相同。
临床怎么用
- 作者认为,活检与切除标本在MMR缺失、MSI高、P53野生型及异常型方面一致性高,可提供更早、更可靠的预后信息以指导管理。
局限性
- 由于本研究中POLE突变频率低,POLE突变未能达到类似的一致性。
- POLE基因突变仅在2例患者中检出,且两例均仅在切除标本中检测到突变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The current risk stratification systems used to guide management of endometrial cancer are based on irreproducible post surgical pathological information, hence the need for more reliable classification systems. Using microarray and sequencing technologies, TCGA recently identified four prognostically significant endometrial carcinoma subtypes, which subsequently proved reproducible using clinically applicable surrogate tests. Using these tests, we sought to determine the level of concordance between endometrial biopsies and subsequent hysterectomy specimens in assessing the molecular classification of endometrial carcinoma. MATERIALS AND METHODS: Fifty biopsies with corresponding hysterectomy specimens for endometrial carcinomas were collected. Additionally, 10 cases of biopsy proven atypical hyperplasia/EIN who were found to have endometrial carcinoma on resection were included. IHC for mismatch repair (MMR) proteins (MLH1, PMS2, MSH2 and MSH6) and P53 was performed. Microsatellite instability analysis was performed by PCR and Sanger sequencing was performed to detect mutations in exons 9 and 13 of the POLE gene. The level of concordance for tumor grade, histologic subtype, immunohistochemical and molecular profile in both specimens was determined using Cohen's kappa estimates. RESULTS: A high level of concordance was achieved for MMR-loss, MSI-high, P53-wild and abnormal types. In contrast, grade and histologic subtype showed only moderate levels of agreement. POLE gene mutation was detected in two patients. For both cases, mutations were detected only in resection specimens. When comparing atypical hyperplasia/EIN with subsequent hysterectomy tumor, the profile was identical to that of endometrial carcinoma. CONCLUSION: In our cohort of endometrial carcinoma, a high level of concordance was achieved between biopsy and hysterectomy specimens for MMR-loss, MSI-high, P53-wild and abnormal types, superior to that of grade and histologic subtype, providing earlier and more reliable prognostic information to inform management. Similar concordance could not be achieved for POLE mutation, given the low frequency of this mutation in our study.
引用
- Abdulfatah E, Wakeling E, Sakr S, et al. Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management. Gynecol Oncol. 2019. PMID: 31248668. doi:10.1016/j.ygyno.2019.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。